nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—melanoma	0.229	0.512	CbGaD
Norethindrone—ABCB1—melanoma	0.219	0.488	CbGaD
Norethindrone—ALB—Vemurafenib—melanoma	0.115	0.283	CbGbCtD
Norethindrone—CYP3A4—Temozolomide—melanoma	0.0656	0.162	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0422	0.104	CbGbCtD
Norethindrone—CYP3A7—Docetaxel—melanoma	0.0422	0.104	CbGbCtD
Norethindrone—ABCB1—Dactinomycin—melanoma	0.0399	0.0984	CbGbCtD
Norethindrone—CYP3A4—Vemurafenib—melanoma	0.0359	0.0888	CbGbCtD
Norethindrone—CYP3A5—Docetaxel—melanoma	0.0316	0.0781	CbGbCtD
Norethindrone—ABCB1—Docetaxel—melanoma	0.0206	0.0508	CbGbCtD
Norethindrone—CYP3A4—Docetaxel—melanoma	0.0123	0.0305	CbGbCtD
Norethindrone—Erythema nodosum—Vemurafenib—melanoma	0.00466	0.0437	CcSEcCtD
Norethindrone—Infertility—Carmustine—melanoma	0.00409	0.0383	CcSEcCtD
Norethindrone—Infertility—Temozolomide—melanoma	0.00395	0.037	CcSEcCtD
Norethindrone—Thromboembolic event—Docetaxel—melanoma	0.00255	0.0239	CcSEcCtD
Norethindrone—Neoplasm malignant—Vemurafenib—melanoma	0.00236	0.0221	CcSEcCtD
Norethindrone—Cerebral haemorrhage—Carmustine—melanoma	0.00193	0.0181	CcSEcCtD
Norethindrone—Cerebral haemorrhage—Temozolomide—melanoma	0.00186	0.0175	CcSEcCtD
Norethindrone—Deep vein thrombosis—Temozolomide—melanoma	0.00169	0.0159	CcSEcCtD
Norethindrone—Photosensitivity—Vemurafenib—melanoma	0.00167	0.0156	CcSEcCtD
Norethindrone—Embolism—Temozolomide—melanoma	0.00161	0.0151	CcSEcCtD
Norethindrone—Digestion impaired—Temozolomide—melanoma	0.00154	0.0145	CcSEcCtD
Norethindrone—Thrombosis—Carmustine—melanoma	0.00151	0.0141	CcSEcCtD
Norethindrone—Prurigo—Docetaxel—melanoma	0.00149	0.0139	CcSEcCtD
Norethindrone—Pain in extremity—Vemurafenib—melanoma	0.00146	0.0137	CcSEcCtD
Norethindrone—Tenderness—Bleomycin—melanoma	0.0014	0.0131	CcSEcCtD
Norethindrone—Vaginal haemorrhage—Temozolomide—melanoma	0.00139	0.0131	CcSEcCtD
Norethindrone—Menorrhagia—Temozolomide—melanoma	0.00139	0.0131	CcSEcCtD
Norethindrone—Menstruation irregular—Docetaxel—melanoma	0.00124	0.0116	CcSEcCtD
Norethindrone—Breast pain—Temozolomide—melanoma	0.00118	0.0111	CcSEcCtD
Norethindrone—Amenorrhoea—Temozolomide—melanoma	0.00117	0.011	CcSEcCtD
Norethindrone—Photosensitivity reaction—Vemurafenib—melanoma	0.00116	0.0108	CcSEcCtD
Norethindrone—Deep vein thrombosis—Docetaxel—melanoma	0.00113	0.0106	CcSEcCtD
Norethindrone—Embolism—Docetaxel—melanoma	0.00107	0.01	CcSEcCtD
Norethindrone—Pulmonary embolism—Carmustine—melanoma	0.00107	0.01	CcSEcCtD
Norethindrone—Pulmonary embolism—Temozolomide—melanoma	0.00103	0.00967	CcSEcCtD
Norethindrone—Connective tissue disorder—Vemurafenib—melanoma	0.000996	0.00933	CcSEcCtD
Norethindrone—Erythema multiforme—Vemurafenib—melanoma	0.000958	0.00898	CcSEcCtD
Norethindrone—Dermatitis atopic—Docetaxel—melanoma	0.000926	0.00868	CcSEcCtD
Norethindrone—Alopecia—Vemurafenib—melanoma	0.000895	0.00839	CcSEcCtD
Norethindrone—Thrombophlebitis—Carmustine—melanoma	0.000895	0.00839	CcSEcCtD
Norethindrone—Thrombophlebitis—Temozolomide—melanoma	0.000865	0.0081	CcSEcCtD
Norethindrone—Testosterone Propionate—CYP17A1—melanoma	0.000789	0.327	CrCbGaD
Norethindrone—Amenorrhoea—Docetaxel—melanoma	0.00078	0.00731	CcSEcCtD
Norethindrone—Purpura—Temozolomide—melanoma	0.000777	0.00728	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000746	0.00699	CcSEcCtD
Norethindrone—Affect lability—Temozolomide—melanoma	0.000737	0.00691	CcSEcCtD
Norethindrone—Anaphylactic shock—Vemurafenib—melanoma	0.00072	0.00675	CcSEcCtD
Norethindrone—Mood swings—Temozolomide—melanoma	0.000709	0.00665	CcSEcCtD
Norethindrone—Skin disorder—Vemurafenib—melanoma	0.000699	0.00655	CcSEcCtD
Norethindrone—Pulmonary embolism—Docetaxel—melanoma	0.000686	0.00643	CcSEcCtD
Norethindrone—Breast disorder—Temozolomide—melanoma	0.000676	0.00634	CcSEcCtD
Norethindrone—Acute coronary syndrome—Bleomycin—melanoma	0.000674	0.00632	CcSEcCtD
Norethindrone—Myocardial infarction—Bleomycin—melanoma	0.00067	0.00628	CcSEcCtD
Norethindrone—Abdominal distension—Temozolomide—melanoma	0.000651	0.0061	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000621	0.00582	CcSEcCtD
Norethindrone—Fatigue—Vemurafenib—melanoma	0.000621	0.00582	CcSEcCtD
Norethindrone—Haemoglobin—Bleomycin—melanoma	0.000617	0.00578	CcSEcCtD
Norethindrone—Haemorrhage—Bleomycin—melanoma	0.000614	0.00575	CcSEcCtD
Norethindrone—Depression—Carmustine—melanoma	0.000595	0.00558	CcSEcCtD
Norethindrone—Photosensitivity reaction—Temozolomide—melanoma	0.00059	0.00553	CcSEcCtD
Norethindrone—Weight increased—Temozolomide—melanoma	0.000589	0.00552	CcSEcCtD
Norethindrone—Renal failure—Carmustine—melanoma	0.000587	0.0055	CcSEcCtD
Norethindrone—Depression—Temozolomide—melanoma	0.000575	0.00539	CcSEcCtD
Norethindrone—Thrombophlebitis—Docetaxel—melanoma	0.000575	0.00539	CcSEcCtD
Norethindrone—Hepatitis—Dactinomycin—melanoma	0.000572	0.00537	CcSEcCtD
Norethindrone—Hepatobiliary disease—Temozolomide—melanoma	0.000545	0.00511	CcSEcCtD
Norethindrone—Alopecia—Bleomycin—melanoma	0.000542	0.00508	CcSEcCtD
Norethindrone—Erythema multiforme—Dactinomycin—melanoma	0.000541	0.00507	CcSEcCtD
Norethindrone—Haemoglobin—Carmustine—melanoma	0.000538	0.00505	CcSEcCtD
Norethindrone—Haemorrhage—Carmustine—melanoma	0.000536	0.00502	CcSEcCtD
Norethindrone—Hypersensitivity—Vemurafenib—melanoma	0.00053	0.00497	CcSEcCtD
Norethindrone—Connective tissue disorder—Carmustine—melanoma	0.000526	0.00494	CcSEcCtD
Norethindrone—Renal impairment—Docetaxel—melanoma	0.000523	0.0049	CcSEcCtD
Norethindrone—Haemoglobin—Temozolomide—melanoma	0.00052	0.00488	CcSEcCtD
Norethindrone—Haemorrhage—Temozolomide—melanoma	0.000518	0.00485	CcSEcCtD
Norethindrone—Hepatitis—Temozolomide—melanoma	0.000518	0.00485	CcSEcCtD
Norethindrone—Asthenia—Vemurafenib—melanoma	0.000516	0.00484	CcSEcCtD
Norethindrone—Pruritus—Vemurafenib—melanoma	0.000509	0.00477	CcSEcCtD
Norethindrone—Connective tissue disorder—Temozolomide—melanoma	0.000509	0.00477	CcSEcCtD
Norethindrone—Alopecia—Dactinomycin—melanoma	0.000506	0.00474	CcSEcCtD
Norethindrone—Pain in extremity—Docetaxel—melanoma	0.000498	0.00467	CcSEcCtD
Norethindrone—Migraine—Docetaxel—melanoma	0.00049	0.00459	CcSEcCtD
Norethindrone—Erythema multiforme—Temozolomide—melanoma	0.00049	0.00459	CcSEcCtD
Norethindrone—Dizziness—Vemurafenib—melanoma	0.000476	0.00446	CcSEcCtD
Norethindrone—Alopecia—Carmustine—melanoma	0.000473	0.00444	CcSEcCtD
Norethindrone—Mental disorder—Carmustine—melanoma	0.000469	0.0044	CcSEcCtD
Norethindrone—Immune system disorder—Temozolomide—melanoma	0.000468	0.00438	CcSEcCtD
Norethindrone—Vomiting—Vemurafenib—melanoma	0.000458	0.00429	CcSEcCtD
Norethindrone—Alopecia—Temozolomide—melanoma	0.000458	0.00429	CcSEcCtD
Norethindrone—Rash—Vemurafenib—melanoma	0.000454	0.00425	CcSEcCtD
Norethindrone—Mental disorder—Temozolomide—melanoma	0.000454	0.00425	CcSEcCtD
Norethindrone—Dermatitis—Vemurafenib—melanoma	0.000453	0.00425	CcSEcCtD
Norethindrone—Headache—Vemurafenib—melanoma	0.000451	0.00423	CcSEcCtD
Norethindrone—Breast disorder—Docetaxel—melanoma	0.00045	0.00422	CcSEcCtD
Norethindrone—Anaphylactic shock—Bleomycin—melanoma	0.000436	0.00409	CcSEcCtD
Norethindrone—Oedema—Bleomycin—melanoma	0.000436	0.00409	CcSEcCtD
Norethindrone—Nausea—Vemurafenib—melanoma	0.000428	0.00401	CcSEcCtD
Norethindrone—Oedema—Dactinomycin—melanoma	0.000407	0.00381	CcSEcCtD
Norethindrone—Convulsion—Carmustine—melanoma	0.000404	0.00379	CcSEcCtD
Norethindrone—Weight increased—Docetaxel—melanoma	0.000391	0.00367	CcSEcCtD
Norethindrone—Convulsion—Temozolomide—melanoma	0.000391	0.00366	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000381	0.00357	CcSEcCtD
Norethindrone—Oedema—Carmustine—melanoma	0.000381	0.00357	CcSEcCtD
Norethindrone—Acute coronary syndrome—Docetaxel—melanoma	0.000378	0.00354	CcSEcCtD
Norethindrone—Renal failure—Docetaxel—melanoma	0.000377	0.00353	CcSEcCtD
Norethindrone—Myocardial infarction—Docetaxel—melanoma	0.000376	0.00352	CcSEcCtD
Norethindrone—Oedema—Temozolomide—melanoma	0.000368	0.00345	CcSEcCtD
Norethindrone—Anaphylactic shock—Temozolomide—melanoma	0.000368	0.00345	CcSEcCtD
Norethindrone—Hepatobiliary disease—Docetaxel—melanoma	0.000363	0.0034	CcSEcCtD
Norethindrone—Progesterone—CYP17A1—melanoma	0.000362	0.15	CrCbGaD
Norethindrone—Skin disorder—Temozolomide—melanoma	0.000357	0.00335	CcSEcCtD
Norethindrone—Fatigue—Dactinomycin—melanoma	0.000351	0.00329	CcSEcCtD
Norethindrone—Urticaria—Bleomycin—melanoma	0.000346	0.00325	CcSEcCtD
Norethindrone—Haemoglobin—Docetaxel—melanoma	0.000346	0.00324	CcSEcCtD
Norethindrone—Haemorrhage—Docetaxel—melanoma	0.000344	0.00323	CcSEcCtD
Norethindrone—Hepatitis—Docetaxel—melanoma	0.000344	0.00323	CcSEcCtD
Norethindrone—Insomnia—Carmustine—melanoma	0.000344	0.00323	CcSEcCtD
Norethindrone—Somnolence—Carmustine—melanoma	0.000338	0.00317	CcSEcCtD
Norethindrone—Connective tissue disorder—Docetaxel—melanoma	0.000338	0.00317	CcSEcCtD
Norethindrone—Insomnia—Temozolomide—melanoma	0.000333	0.00312	CcSEcCtD
Norethindrone—Gastrointestinal pain—Dactinomycin—melanoma	0.000333	0.00312	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Carmustine—melanoma	0.000329	0.00308	CcSEcCtD
Norethindrone—Somnolence—Temozolomide—melanoma	0.000327	0.00307	CcSEcCtD
Norethindrone—Erythema multiforme—Docetaxel—melanoma	0.000326	0.00305	CcSEcCtD
Norethindrone—Dyspepsia—Temozolomide—melanoma	0.000324	0.00304	CcSEcCtD
Norethindrone—Abdominal pain—Dactinomycin—melanoma	0.000321	0.00301	CcSEcCtD
Norethindrone—Hypersensitivity—Bleomycin—melanoma	0.000321	0.00301	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Temozolomide—melanoma	0.000318	0.00298	CcSEcCtD
Norethindrone—Fatigue—Temozolomide—melanoma	0.000317	0.00297	CcSEcCtD
Norethindrone—Asthenia—Bleomycin—melanoma	0.000313	0.00293	CcSEcCtD
Norethindrone—Gastrointestinal pain—Carmustine—melanoma	0.000311	0.00292	CcSEcCtD
Norethindrone—Immune system disorder—Docetaxel—melanoma	0.000311	0.00292	CcSEcCtD
Norethindrone—Pruritus—Bleomycin—melanoma	0.000309	0.00289	CcSEcCtD
Norethindrone—Alopecia—Docetaxel—melanoma	0.000304	0.00285	CcSEcCtD
Norethindrone—Mental disorder—Docetaxel—melanoma	0.000302	0.00283	CcSEcCtD
Norethindrone—Abdominal pain—Carmustine—melanoma	0.000301	0.00282	CcSEcCtD
Norethindrone—Gastrointestinal pain—Temozolomide—melanoma	0.000301	0.00282	CcSEcCtD
Norethindrone—Hypersensitivity—Dactinomycin—melanoma	0.0003	0.00281	CcSEcCtD
Norethindrone—Urticaria—Temozolomide—melanoma	0.000292	0.00274	CcSEcCtD
Norethindrone—Asthenia—Dactinomycin—melanoma	0.000292	0.00274	CcSEcCtD
Norethindrone—Abdominal pain—Temozolomide—melanoma	0.000291	0.00273	CcSEcCtD
Norethindrone—Hypersensitivity—Carmustine—melanoma	0.00028	0.00263	CcSEcCtD
Norethindrone—Vomiting—Bleomycin—melanoma	0.000277	0.0026	CcSEcCtD
Norethindrone—Rash—Bleomycin—melanoma	0.000275	0.00258	CcSEcCtD
Norethindrone—Dermatitis—Bleomycin—melanoma	0.000275	0.00258	CcSEcCtD
Norethindrone—Asthenia—Carmustine—melanoma	0.000273	0.00256	CcSEcCtD
Norethindrone—Hypersensitivity—Temozolomide—melanoma	0.000271	0.00254	CcSEcCtD
Norethindrone—Asthenia—Temozolomide—melanoma	0.000264	0.00247	CcSEcCtD
Norethindrone—Pruritus—Temozolomide—melanoma	0.00026	0.00244	CcSEcCtD
Norethindrone—Convulsion—Docetaxel—melanoma	0.00026	0.00243	CcSEcCtD
Norethindrone—Nausea—Bleomycin—melanoma	0.000259	0.00243	CcSEcCtD
Norethindrone—Vomiting—Dactinomycin—melanoma	0.000259	0.00242	CcSEcCtD
Norethindrone—Rash—Dactinomycin—melanoma	0.000256	0.0024	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000253	0.00238	CcSEcCtD
Norethindrone—Dizziness—Carmustine—melanoma	0.000252	0.00236	CcSEcCtD
Norethindrone—Progesterone—CYP1B1—melanoma	0.000251	0.104	CrCbGaD
Norethindrone—Oedema—Docetaxel—melanoma	0.000245	0.00229	CcSEcCtD
Norethindrone—Anaphylactic shock—Docetaxel—melanoma	0.000245	0.00229	CcSEcCtD
Norethindrone—Dizziness—Temozolomide—melanoma	0.000243	0.00228	CcSEcCtD
Norethindrone—Vomiting—Carmustine—melanoma	0.000242	0.00227	CcSEcCtD
Norethindrone—Nausea—Dactinomycin—melanoma	0.000242	0.00226	CcSEcCtD
Norethindrone—Rash—Carmustine—melanoma	0.00024	0.00225	CcSEcCtD
Norethindrone—Dermatitis—Carmustine—melanoma	0.00024	0.00225	CcSEcCtD
Norethindrone—Headache—Carmustine—melanoma	0.000238	0.00224	CcSEcCtD
Norethindrone—Skin disorder—Docetaxel—melanoma	0.000238	0.00223	CcSEcCtD
Norethindrone—Testosterone—CYP1B1—melanoma	0.000237	0.0985	CrCbGaD
Norethindrone—Vomiting—Temozolomide—melanoma	0.000234	0.00219	CcSEcCtD
Norethindrone—Rash—Temozolomide—melanoma	0.000232	0.00217	CcSEcCtD
Norethindrone—Dermatitis—Temozolomide—melanoma	0.000232	0.00217	CcSEcCtD
Norethindrone—Headache—Temozolomide—melanoma	0.00023	0.00216	CcSEcCtD
Norethindrone—Nausea—Carmustine—melanoma	0.000226	0.00212	CcSEcCtD
Norethindrone—Insomnia—Docetaxel—melanoma	0.000221	0.00207	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—melanoma	0.00022	0.0912	CrCbGaD
Norethindrone—Nausea—Temozolomide—melanoma	0.000218	0.00205	CcSEcCtD
Norethindrone—Somnolence—Docetaxel—melanoma	0.000217	0.00204	CcSEcCtD
Norethindrone—Dyspepsia—Docetaxel—melanoma	0.000215	0.00202	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Docetaxel—melanoma	0.000211	0.00198	CcSEcCtD
Norethindrone—Fatigue—Docetaxel—melanoma	0.000211	0.00198	CcSEcCtD
Norethindrone—Gastrointestinal pain—Docetaxel—melanoma	0.0002	0.00188	CcSEcCtD
Norethindrone—Abdominal pain—Docetaxel—melanoma	0.000193	0.00181	CcSEcCtD
Norethindrone—Hypersensitivity—Docetaxel—melanoma	0.00018	0.00169	CcSEcCtD
Norethindrone—Asthenia—Docetaxel—melanoma	0.000176	0.00165	CcSEcCtD
Norethindrone—Pruritus—Docetaxel—melanoma	0.000173	0.00162	CcSEcCtD
Norethindrone—Dizziness—Docetaxel—melanoma	0.000162	0.00152	CcSEcCtD
Norethindrone—Vomiting—Docetaxel—melanoma	0.000156	0.00146	CcSEcCtD
Norethindrone—Rash—Docetaxel—melanoma	0.000154	0.00145	CcSEcCtD
Norethindrone—Dermatitis—Docetaxel—melanoma	0.000154	0.00144	CcSEcCtD
Norethindrone—Headache—Docetaxel—melanoma	0.000153	0.00144	CcSEcCtD
Norethindrone—Nausea—Docetaxel—melanoma	0.000145	0.00136	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ABCB1—melanoma	0.000129	0.0533	CrCbGaD
Norethindrone—Methyltestosterone—ALB—melanoma	0.000123	0.051	CrCbGaD
Norethindrone—Hydrocortisone—ABCB1—melanoma	8.85e-05	0.0367	CrCbGaD
Norethindrone—Progesterone—ABCB1—melanoma	7.21e-05	0.0299	CrCbGaD
Norethindrone—Testosterone—ALB—melanoma	7.14e-05	0.0296	CrCbGaD
Norethindrone—Testosterone—ABCB1—melanoma	6.81e-05	0.0283	CrCbGaD
Norethindrone—CYP3A5—Metabolism—PLA2G6—melanoma	1.36e-05	0.000353	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PDGFRA—melanoma	1.35e-05	0.000351	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HPSE—melanoma	1.35e-05	0.00035	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GNA11—melanoma	1.35e-05	0.00035	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PHGDH—melanoma	1.34e-05	0.000348	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LUM—melanoma	1.34e-05	0.000348	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HS3ST5—melanoma	1.34e-05	0.000347	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PRKCA—melanoma	1.34e-05	0.000347	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ITGB3—melanoma	1.34e-05	0.000347	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CUBN—melanoma	1.32e-05	0.000344	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—FASN—melanoma	1.32e-05	0.000342	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HPSE—melanoma	1.31e-05	0.000342	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.31e-05	0.000341	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SPP1—melanoma	1.31e-05	0.00034	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAP2K2—melanoma	1.31e-05	0.000339	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SLC5A5—melanoma	1.3e-05	0.000337	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—RAC1—melanoma	1.29e-05	0.000336	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CUBN—melanoma	1.29e-05	0.000335	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SDHD—melanoma	1.28e-05	0.000332	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—BSG—melanoma	1.28e-05	0.000332	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CSPG4—melanoma	1.28e-05	0.000332	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.27e-05	0.00033	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MMP1—melanoma	1.25e-05	0.000325	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CD44—melanoma	1.25e-05	0.000325	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GNAQ—melanoma	1.25e-05	0.000325	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.25e-05	0.000325	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SDHD—melanoma	1.25e-05	0.000324	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CSPG4—melanoma	1.25e-05	0.000324	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—BSG—melanoma	1.25e-05	0.000324	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TERT—melanoma	1.24e-05	0.000323	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RAC1—melanoma	1.24e-05	0.000322	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPAM—melanoma	1.24e-05	0.000321	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CDK2—melanoma	1.23e-05	0.000319	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—VCAN—melanoma	1.22e-05	0.000317	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPAM—melanoma	1.21e-05	0.000314	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.2e-05	0.000312	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP1B1—melanoma	1.2e-05	0.000312	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HIF1A—melanoma	1.19e-05	0.000309	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.18e-05	0.000307	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLA2G6—melanoma	1.17e-05	0.000304	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.15e-05	0.000299	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—FN1—melanoma	1.14e-05	0.000297	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.14e-05	0.000297	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KDR—melanoma	1.14e-05	0.000295	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS2—melanoma	1.13e-05	0.000294	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.12e-05	0.000292	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.12e-05	0.000292	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CG—melanoma	1.09e-05	0.000284	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FN1—melanoma	1.09e-05	0.000284	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—EGF—melanoma	1.08e-05	0.000281	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.07e-05	0.000278	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NOTCH1—melanoma	1.07e-05	0.000278	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.06e-05	0.000276	CbGpPWpGaD
Norethindrone—ALB—Metabolism—VCAN—melanoma	1.05e-05	0.000273	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLA2G6—melanoma	1.05e-05	0.000273	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CD80—melanoma	1.05e-05	0.000272	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APC—melanoma	1.05e-05	0.000272	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KIT—melanoma	1.05e-05	0.000272	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CG—melanoma	1.05e-05	0.000272	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EGF—melanoma	1.03e-05	0.000269	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP17A1—melanoma	1.03e-05	0.000268	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLA2G6—melanoma	1.03e-05	0.000267	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLCB4—melanoma	1.01e-05	0.000263	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF1—melanoma	1e-05	0.00026	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.95e-06	0.000259	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	9.91e-06	0.000258	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCB1—melanoma	9.88e-06	0.000257	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BRAF—melanoma	9.83e-06	0.000256	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	9.76e-06	0.000254	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GNA11—melanoma	9.73e-06	0.000253	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CD—melanoma	9.61e-06	0.00025	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.61e-06	0.00025	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1—melanoma	9.58e-06	0.000249	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC6A11—melanoma	9.52e-06	0.000248	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIP4K2A—melanoma	9.52e-06	0.000248	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—FASN—melanoma	9.52e-06	0.000248	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—VCAN—melanoma	9.44e-06	0.000245	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.44e-06	0.000245	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC5A5—melanoma	9.37e-06	0.000243	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTAP—melanoma	9.26e-06	0.000241	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAP2K1—melanoma	9.26e-06	0.000241	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—VCAN—melanoma	9.21e-06	0.00024	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CD—melanoma	9.2e-06	0.000239	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MAPK3—melanoma	9.1e-06	0.000237	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PRKCA—melanoma	9.09e-06	0.000236	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CD44—melanoma	9.05e-06	0.000235	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GNAQ—melanoma	9.05e-06	0.000235	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ERCC2—melanoma	9.02e-06	0.000234	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.94e-06	0.000232	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP17A1—melanoma	8.87e-06	0.000231	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MYC—melanoma	8.85e-06	0.00023	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGF2—melanoma	8.8e-06	0.000229	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.75e-06	0.000227	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP1B1—melanoma	8.67e-06	0.000225	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.62e-06	0.000224	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GNA11—melanoma	8.38e-06	0.000218	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CB—melanoma	8.38e-06	0.000218	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LUM—melanoma	8.26e-06	0.000215	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PHGDH—melanoma	8.26e-06	0.000215	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MDM2—melanoma	8.24e-06	0.000214	CbGpPWpGaD
Norethindrone—ALB—Metabolism—FASN—melanoma	8.2e-06	0.000213	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ERBB2—melanoma	8.12e-06	0.000211	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HPSE—melanoma	8.1e-06	0.00021	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	8.09e-06	0.00021	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC5A5—melanoma	8.07e-06	0.00021	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CB—melanoma	8.01e-06	0.000208	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	7.97e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP17A1—melanoma	7.96e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CUBN—melanoma	7.95e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.86e-06	0.000204	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CD44—melanoma	7.79e-06	0.000203	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GNAQ—melanoma	7.79e-06	0.000203	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP17A1—melanoma	7.77e-06	0.000202	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	7.76e-06	0.000202	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CXCL8—melanoma	7.7e-06	0.0002	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IL2—melanoma	7.69e-06	0.0002	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CSPG4—melanoma	7.67e-06	0.0002	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—BSG—melanoma	7.67e-06	0.0002	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SDHD—melanoma	7.67e-06	0.0002	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.63e-06	0.000198	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.56e-06	0.000196	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GNA11—melanoma	7.52e-06	0.000196	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1B—melanoma	7.52e-06	0.000196	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP1B1—melanoma	7.47e-06	0.000194	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPAM—melanoma	7.43e-06	0.000193	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—melanoma	7.37e-06	0.000192	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FASN—melanoma	7.36e-06	0.000191	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL2—melanoma	7.36e-06	0.000191	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GNA11—melanoma	7.34e-06	0.000191	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC5A5—melanoma	7.24e-06	0.000188	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	7.2e-06	0.000187	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FASN—melanoma	7.18e-06	0.000187	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCND1—melanoma	7.18e-06	0.000187	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCB1—melanoma	7.14e-06	0.000186	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CG—melanoma	7.12e-06	0.000185	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CTNNB1—melanoma	7.11e-06	0.000185	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC5A5—melanoma	7.07e-06	0.000184	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GNAQ—melanoma	6.99e-06	0.000182	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CD44—melanoma	6.99e-06	0.000182	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—melanoma	6.97e-06	0.000181	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1A—melanoma	6.94e-06	0.00018	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTEN—melanoma	6.93e-06	0.00018	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NFKB1—melanoma	6.89e-06	0.000179	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—melanoma	6.87e-06	0.000179	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.85e-06	0.000178	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GNAQ—melanoma	6.83e-06	0.000177	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CD44—melanoma	6.83e-06	0.000177	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.78e-06	0.000176	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP1B1—melanoma	6.7e-06	0.000174	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.59e-06	0.000171	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PRKCA—melanoma	6.57e-06	0.000171	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP1B1—melanoma	6.54e-06	0.00017	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—melanoma	6.54e-06	0.00017	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ERCC2—melanoma	6.52e-06	0.000169	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NRAS—melanoma	6.46e-06	0.000168	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLA2G6—melanoma	6.32e-06	0.000164	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CD—melanoma	6.26e-06	0.000163	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—melanoma	6.26e-06	0.000163	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—STAT3—melanoma	6.19e-06	0.000161	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK3—melanoma	6.19e-06	0.000161	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—melanoma	6.18e-06	0.000161	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NRAS—melanoma	6.18e-06	0.000161	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCB1—melanoma	6.15e-06	0.00016	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—melanoma	6.14e-06	0.00016	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK3—melanoma	5.92e-06	0.000154	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.92e-06	0.000154	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK1—melanoma	5.89e-06	0.000153	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—melanoma	5.76e-06	0.00015	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—VCAN—melanoma	5.68e-06	0.000148	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PRKCA—melanoma	5.66e-06	0.000147	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK1—melanoma	5.63e-06	0.000146	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EGFR—melanoma	5.63e-06	0.000146	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ERCC2—melanoma	5.61e-06	0.000146	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—KRAS—melanoma	5.56e-06	0.000145	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCB1—melanoma	5.52e-06	0.000144	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CB—melanoma	5.46e-06	0.000142	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—melanoma	5.41e-06	0.000141	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KRAS—melanoma	5.32e-06	0.000138	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CG—melanoma	5.15e-06	0.000134	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—melanoma	5.11e-06	0.000133	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PRKCA—melanoma	5.08e-06	0.000132	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ERCC2—melanoma	5.04e-06	0.000131	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—melanoma	4.97e-06	0.000129	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PRKCA—melanoma	4.96e-06	0.000129	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—melanoma	4.94e-06	0.000128	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ERCC2—melanoma	4.92e-06	0.000128	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—melanoma	4.89e-06	0.000127	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP17A1—melanoma	4.79e-06	0.000125	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—melanoma	4.73e-06	0.000123	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HRAS—melanoma	4.73e-06	0.000123	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTEN—melanoma	4.72e-06	0.000123	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.65e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CD—melanoma	4.53e-06	0.000118	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GNA11—melanoma	4.52e-06	0.000118	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HRAS—melanoma	4.52e-06	0.000118	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—melanoma	4.47e-06	0.000116	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CG—melanoma	4.43e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FASN—melanoma	4.43e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC5A5—melanoma	4.35e-06	0.000113	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—melanoma	4.33e-06	0.000112	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—melanoma	4.28e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GNAQ—melanoma	4.21e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CD44—melanoma	4.21e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.17e-06	0.000109	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—melanoma	4.17e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP1B1—melanoma	4.03e-06	0.000105	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—melanoma	3.99e-06	0.000104	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CG—melanoma	3.98e-06	0.000103	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CB—melanoma	3.94e-06	0.000103	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—melanoma	3.91e-06	0.000102	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CD—melanoma	3.9e-06	0.000101	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CG—melanoma	3.88e-06	0.000101	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—melanoma	3.84e-06	9.99e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—melanoma	3.75e-06	9.75e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CD—melanoma	3.5e-06	9.09e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—melanoma	3.45e-06	8.98e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CD—melanoma	3.41e-06	8.88e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTEN—melanoma	3.41e-06	8.86e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CB—melanoma	3.4e-06	8.83e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—melanoma	3.37e-06	8.76e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—melanoma	3.37e-06	8.75e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—melanoma	3.33e-06	8.65e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCB1—melanoma	3.32e-06	8.63e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PRKCA—melanoma	3.06e-06	7.94e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CB—melanoma	3.05e-06	7.93e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ERCC2—melanoma	3.03e-06	7.88e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—melanoma	3.02e-06	7.85e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CB—melanoma	2.98e-06	7.74e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—melanoma	2.95e-06	7.67e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTEN—melanoma	2.94e-06	7.63e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—melanoma	2.72e-06	7.06e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTEN—melanoma	2.64e-06	6.85e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTEN—melanoma	2.57e-06	6.69e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—melanoma	2.4e-06	6.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CG—melanoma	2.39e-06	6.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—melanoma	2.31e-06	6e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CD—melanoma	2.1e-06	5.47e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—melanoma	2.08e-06	5.4e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—melanoma	2.07e-06	5.38e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—melanoma	1.96e-06	5.11e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—melanoma	1.86e-06	4.83e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CB—melanoma	1.83e-06	4.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—melanoma	1.82e-06	4.72e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—melanoma	1.81e-06	4.72e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—melanoma	1.69e-06	4.4e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTEN—melanoma	1.58e-06	4.12e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—melanoma	1.52e-06	3.95e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—melanoma	1.48e-06	3.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—melanoma	1.12e-06	2.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—melanoma	9.13e-07	2.37e-05	CbGpPWpGaD
